Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
CH.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BA.2.75.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.66EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
BN.1.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
BA.5.2.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.84EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.84EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EU.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.97EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.59EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used